How to Buy Agios Pharmaceuticals Stock
Agios Pharmaceuticals Inc
Agios Pharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology.
Agios Pharmaceuticals stock last closed at $29.10, down 1.76% from the previous day, and has decreased 11.17% in one year. It has overperformed other stocks in the Biotechnology industry by 0.66 percentage points. Agios Pharmaceuticals stock is currently +24.28% from its 52-week low of $23.42, and -53.5% from its 52-week high of $62.58.
As of Apr 29, 2025, there are 57.3M shares of AGIO outstanding. The market value of AGIO is $1.67B. In the past 24 hours, 469,988 AGIO shares were traded.
How to Buy Agios Pharmaceuticals Stock
Not sure how to invest in Agios Pharmaceuticals stock? Here's how.
- Figure out where to buy Agios Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you choose where to buy Agios Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Choose your payment method and add your details.
- Analyze Agios Pharmaceuticals stock: The Agios Pharmaceuticals ticker symbol is AGIO. Is Agios Pharmaceuticals stock a good investment? Should you buy shares of AGIO? How do AGIO's underlying business fundamentals look? Do top analysts think Agios Pharmaceuticals is a good buy? Why has AGIO's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if AGIO is a good stock to buy).
- Place your AGIO buy order: Decide if you will purchase AGIO shares at the current market price or use a limit order to buy AGIO stock at a given price.
- Get updates on your AGIO position: Create a watchlist to the latest updates on your new investment in Agios Pharmaceuticals stock.
Step 1: Figure out where to buy Agios Pharmaceuticals stock
You will need an online brokerage account to access the NASDAQ market and buy AGIO stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, you need to fill out some personal information so you are able to buy AGIO today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create your new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have created your account on the greatest app to buy stocks, your next step is to transfer the money for your investment:
Check out this video walkthrough for more details transferring funds into your new brokerage account.
Step 4: Analyze Agios Pharmaceuticals stock
After you have chosen the best place to buy Agios Pharmaceuticals stock, it's important to research their stock before you invest, so you truly wrap your head around the risk and upside.
Agios Pharmaceuticals quick stats
Fundamentals of AGIO
WallStreetZen was created to help everyday investors do better fundamental analysis quickly.
You can view all of the due diligence checks on AGIO's stock page.
Is AGIO stock undervalued or overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge AGIO's true value.
Using relative valuations metrics:
- AGIO could be undervalued based on its P/E ratio of 2.45x, relative to Biotechnology industry P/E ratio of -158.75x
- AGIO could be undervalued based on its P/B ratio of 1.08x, relative to Biotechnology industry P/B ratio of 4.37x
You can access more valuation analysis on AGIO's stock here.
AGIO Financial Health Summary
Signs that AGIO is financially healthy:
- AGIO profit margin has gone up from -1,312.6% to 1,845.9% in the past year.
- There are more short-term assets than short-term liabilities on the AGIO balance sheet.
- Total AGIO debt is lower than 5 years ago, relative to shareholder equity.
- AGIO has a low debt to equity ratio of 0.08.
- AGIO has $893.71M in cash and short term investments. This is sufficient to cover its annual cash burn of $391.49M.
- There are more short-term assets than long-term liabilities on the AGIO balance sheet.
- AGIO has cash burn of 391486000. It has enough cash and short-term investments to cover this for at least one year.
Do analysts think it's a good time to buy Agios Pharmaceuticals stock
Out of 3 Equities analysts who give forecasts on AGIO, the consensus analyst rating on AGIO is a Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Agios Pharmaceuticals stock forecast page.
Metrics for Advanced AGIO Traders
AGIO Growth Metrics
Last year, AGIO earnings were $673.73M. During the last three year, AGIO's earnings have increased by -82.1% per year. This was slower than the Biotechnology industry average of 10.52%.
Last year, AGIO revenue was $36.50M. During the last two year, AGIO's revenue has gone up by 60.1% per year. This was faster than the Biotechnology industry average of 45.47%.
You can analyze AGIO's earnings and revenue performance here.
Who is buying/selling AGIO?
In the last 12 months, executives and large shareholders at AGIO have sold more shares than they have bought.
Jacqualyn A. Fouse, Director of AGIO, was the latest AGIO insider to sell. They sold $194,172.30 worth of AGIO shares on Apr 10, 2025.
Research more about who owns AGIO stock here.
Can I get consistent income from AGIO stock?
No, Agios Pharmaceuticals doesn't provide an income stream by paying out dividends.
AGIO Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your AGIO buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally sufficient. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at an exact price limit, place a limit order.
Click the Open Trade button and your broker will place your order.
If you require more help with buying stocks on eToro, click the how to video below:
Step 6: Get updates on your AGIO position
Now that you own some shares in AGIO, you'll want to stay up-to-date on your investment.
Start a watchlist to get notified of important updates regarding your AGIO stock.
AGIO Feed
How to Buy Stock in Agios Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Agios Pharmaceuticals stock right now:
- Figure out where to buy Agios Pharmaceuticals stock
- Create your brokerage account
- Put funds into your brokerage account
- Analyze Agios Pharmaceuticals stock
- Place your AGIO buy order
- Get updates on your AGIO position
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your investment in Agios Pharmaceuticals, click below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.